MULTIG ENIC THROMBOPHILIA IN PREGNANT WOMAN WITH PREECLAMPSIA.

Authors

  • T. O. Loskutova

DOI:

https://doi.org/10.11603/24116-4944.2016.1.5998

Keywords:

pre-eclampsia, pregnancy, thrombophilia, genetic polymorphisms, risk factors.

Abstract

In order to study the structure and frequency of mutagenic forms of thrombophilia in women with pre-eclampsia were examined 133 patients with varying severity of preeclampsia and 44 healthy pregnant women. Polymerase chain reaction was used to determine the presence of pathological polymorphisms in the genes of thrombophilia (factor V Leiden 1691 G→A, prothrombin 20210 G→A, inhibitor plasminogen activator type-1 5G / 4G, fibrinogen β 455 G→A), «endothelial dysfunction» (paraoxosonase-1 192 Q→R, methylenetetrahydrofolate reductase 677 C→T) and a regulator of blood pressure (angiotensinogen II 235 M→T). It was found that in the development of preeclampsia play the role pathologic polymorphisms, which are mainly found in women with pre-eclampsia. In the structure multigene forms of thrombophilia in mild pre-eclampsia predominated – 71.88 % and in pre-eclampsia moderate and severe degree – 79.7 %. It is noted that mild pre-eclampsia is characterized by the existence of two pathological polymorphisms simultaneously (OR 3.4; 95 % CI 1.47–7.88), preeclampsia moderate and severe degree three or more pathological polymorphism simultaneously (OR=10.51; 95 % CI 2.97–37.26). Lack of co-pathologic polymorphisms reduce the risk of development moderate, severe (OR=0.11; 95 % CI 0.04–0.26) and mild (OR=0.16; 95 % CI 0.07–0.38) preeclampsia.

References

WHO analysis of causes of maternal death: a systematic review / K. S. Khan, D. Wojdyla, L. Say [et al.] // Lancet. – 2006. – Vol. 367. – P. 1066–1074.

Profylaktyka povtornykh oslozhnenyy beremennosty v uslovyyakh trombofylyy : rukovodstvo dlya vrachey / A. D. Makatsaryya, V. O. Bytsadze, S. M. Baymuradova, E. B. Perederyaeva [y dr.]. – M. : «Tryada – KH», 2008. – 152 s.

Maternal and fetal genetic factors account for most of familial aggregation of preeclampsia: A population-based Swedish cohort study / S. Cnattingius, M. Reilly, Y. Pawitan, P. Lichtenstein // Am. J. Medical Genetics Part A. – 2004. – Vol. 130A. – P. 365–371.

Double inherited thrombophilias and adverse pregnancy outcomes: fashion or science? / G. Larciprete, F. Rossi, T. Deaibess [et al.] // J. Obstet. Gynaecol. Res. – 2010. – Vol. 36, No. 5. – R. 996–1002.

Thrombophilias and adverse pregnancy outcomes: results from the Danish National Birth Cohort / J. A. Lykke, L. A. Bare, J. Olsen [et al.] // J. Thromb. Haemost. – 2012. – Vol. 10, No. 7. – R. 1320–1325.

Thrombophilia is significantly associated with severe preeclampsia. Results of a large scale, case-controlled study / G. Mello, E. Paretti, L. Marozio [et al.] // Hypertension. – 2005. – Vol. 46. – P. 1270–1274.

Perinatal outcome in women with severe pregnancy complications and multiple thrombophilias / M. Kupferminc, E. Rimon, J. Ascher-Landsberg [et al.] // J. Perinat Med. – 2004. – Vol. 32, No. 3. – P. 225–227.

Published

2016-04-04

How to Cite

Loskutova, T. O. (2016). MULTIG ENIC THROMBOPHILIA IN PREGNANT WOMAN WITH PREECLAMPSIA. Actual Problems of Pediatrics, Obstetrics and Gynecology, (1). https://doi.org/10.11603/24116-4944.2016.1.5998

Issue

Section

OBSTETRICS AND GYNECOLOGY